Notice2022-14759

Proposed Data Collection Submitted for Public Comment and Recommendations

Primary source

Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.

Published
July 12, 2022

Issuing agencies

Health and Human Services DepartmentCenters for Disease Control and Prevention

Abstract

The Centers for Disease Control and Prevention (CDC), as part of its continuing effort to reduce public burden and maximize the utility of government information, invites the general public and other federal agencies the opportunity to comment on a proposed information collection, as required by the Paperwork Reduction Act of 1995. This notice invites comment on a proposed information collection project titled Milestone Tracker In-App survey to understand the outcome of the Milestone Tracker app on developmental surveillance. This project is designed to evaluate the Milestone Tracker mobile application (app) developed by CDC's "Learn the Signs. Act Early." program and will be used to understand how the app is being used, if users find it helpful, and if the app helped them to identify a possible developmental concern(s).

Full Text

<html>
<head>
<title>Federal Register, Volume 87 Issue 132 (Tuesday, July 12, 2022)</title>
</head>
<body><pre>
[Federal Register Volume 87, Number 132 (Tuesday, July 12, 2022)]
[Notices]
[Pages 41317-41318]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2022-14759]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[60Day-22-22GR; Docket No. CDC-2022-0081]


Proposed Data Collection Submitted for Public Comment and 
Recommendations

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice with comment period.

-----------------------------------------------------------------------

SUMMARY: The Centers for Disease Control and Prevention (CDC), as part 
of its continuing effort to reduce public burden and maximize the 
utility of government information, invites the general public and other 
federal agencies the opportunity to comment on a proposed information 
collection, as required by the Paperwork Reduction Act of 1995. This 
notice invites comment on a proposed information collection project 
titled Milestone Tracker In-App survey to understand the outcome of the 
Milestone Tracker app on developmental surveillance. This project is 
designed to evaluate the Milestone Tracker mobile application (app) 
developed by CDC's ``Learn the Signs. Act Early.'' program and will be 
used to understand how the app is being used, if users find it helpful, 
and if the app helped them to identify a possible developmental 
concern(s).

DATES: CDC must receive written comments on or before September 12, 
2022.

ADDRESSES: You may submit comments, identified by Docket No. CDC-2022-
0081 by either of the following methods:
    <bullet> Federal eRulemaking Portal: <a href="http://www.regulations.gov">www.regulations.gov</a>. Follow 
the instructions for submitting comments.
    <bullet> Mail: Jeffrey M. Zirger, Information Collection Review 
Office, Centers for Disease Control and Prevention, 1600 Clifton Road 
NE, MS H21-8, Atlanta, Georgia 30329.
    Instructions: All submissions received must include the agency name 
and Docket Number. CDC will post, without change, all relevant comments 
to <a href="http://www.regulations.gov">www.regulations.gov</a>.
    Please note: Submit all comments through the Federal eRulemaking 
portal (<a href="http://www.regulations.gov">www.regulations.gov</a>) or by U.S. mail to the address listed 
above.

FOR FURTHER INFORMATION CONTACT: To request more information on the 
proposed project or to obtain a copy of the information collection plan 
and instruments, contact Jeffrey M. Zirger, Information Collection 
Review Office, Centers for Disease Control and Prevention, 1600 Clifton 
Road NE, MS H21-8, Atlanta, Georgia 30329; Telephone: 404-639-7570; 
Email: <a href="/cdn-cgi/l/email-protection#aec1c3cceecdcacd80c9c1d8"><span class="__cf_email__" data-cfemail="17787a755774737439707861">[email&#160;protected]</span></a>.

SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995 
(PRA) (44 U.S.C. 3501-3520), federal agencies must obtain approval from 
the Office of Management and Budget (OMB) for each collection of 
information they conduct or sponsor. In addition, the PRA also requires 
federal agencies to provide a 60-day notice in the Federal Register 
concerning each proposed collection of information, including each new 
proposed collection, each proposed extension of existing collection of 
information, and each reinstatement of previously approved information 
collection before submitting the collection to the OMB for approval. To 
comply with this requirement, we are publishing this notice of a 
proposed data collection as described below.
    The OMB is particularly interested in comments that will help:
    1. Evaluate whether the proposed collection of information is 
necessary for the proper performance of the functions of the agency, 
including whether the information will have practical utility;
    2. Evaluate the accuracy of the agency's estimate of the burden of 
the proposed collection of information, including the validity of the 
methodology and assumptions used;
    3. Enhance the quality, utility, and clarity of the information to 
be collected;
    4. Minimize the burden of the collection of information on those 
who are to respond, including through the use of appropriate automated, 
electronic, mechanical, or other technological collection techniques or 
other forms of information technology, e.g., permitting electronic 
submissions of responses; and
    5. Assess information collection costs.

Proposed Project

    Milestone Tracker In-App Survey to Understand the Outcome of the 
Milestone Tracker App on Developmental Surveillance--New--National 
Center on Birth Defects and Developmental Disabilities (NCBDDD), 
Centers for Disease Control and Prevention (CDC)

[[Page 41318]]

Background and Brief Description

    The Centers for Disease Control and Prevention's ``Learn the Signs. 
Act Early.'' program (LTSAE) promotes efforts to increase developmental 
monitoring across all 50 states, the District of Columbia, and other 
U.S. territories through its Act Early Initiatives and Act Early 
Ambassador program, which heavily promote use of CDC's Milestone 
Tracker app. The app is a tool to help parents and others track and 
monitor their children's developmental milestones and guide them on 
next steps for when a child is missing milestones or there are other 
concerns.
    Since the app release in 2017, the program has had limited 
capability to evaluate target outcomes and impact of use of the app. 
Without directly asking the app users, the program has no way to know 
if use of this app is helpful, has made a difference in terms of 
identifying developmental delays among children, or if it is helping 
children get the services and support they may need as a result. This 
web-based survey evaluation will allow LTSAE to collect this 
information and assess the outcomes and impact of this tool to 
determine if the app is having the intended impact and should be 
continued to be made available as is or with improvements.
    The goal of the LTSAE program is to improve early identification of 
developmental delays and disabilities by developing high-quality, 
evidence informed and parent-friendly tools and resources to facilitate 
ongoing family-engaged developmental monitoring. The Milestone Tracker 
app is one of these tools to help parents and other caregivers track 
early development and link parents and guardians to the appropriate 
care and resources.
    The goal of this project is to evaluate the Milestone Tracker app 
developed by CDC's ``Learn the Signs. Act Early.'' program. The 
evaluation will consist of two brief web surveys at two distinct times 
during the app user experience. The objectives of these two short 
surveys is to understand how the app is being used, if users like the 
app/find it helpful, if the app helped them to identify a possible 
developmental concern, if they plan to use it again, and what happens 
as a result of using the app. The resulting survey data will be used to 
assess user satisfaction with the app as well as to evaluate short term 
and medium-term outcomes associated with its use.
    CDC requests OMB approval for an estimated 8,000 annual burden 
hours. There is no cost to respondents other than their time to 
participate.

                                        Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
                                                                     Number of    Average burden
      Type of respondents           Form name        Number of     responses per   per response    Total burden
                                                    respondents     respondent      (in hours)         hours
----------------------------------------------------------------------------------------------------------------
Individuals using the           Milestone                200,000               1            2/60           6,667
 Milestone Tracker app.          Tracker In app
                                 Baseline Survey.
Individuals using the           Milestone                 40,000               1            2/60           1,333
 Milestone Tracker App that      Tracker App
 have indicated a                Follow-up
 developmental concern.          Survey.
                                                 ---------------------------------------------------------------
    Total.....................  ................  ..............  ..............  ..............           8,000
----------------------------------------------------------------------------------------------------------------


Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Scientific 
Integrity, Office of Science, Centers for Disease Control and 
Prevention.
[FR Doc. 2022-14759 Filed 7-11-22; 8:45 am]
BILLING CODE 4163-18-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
Indexed from Federal Register on July 12, 2022.

This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.